Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-024-07073-y, published online 30 September 2024
In the original version of this article, Fig. 4A does not show the correct resolution of confocal images to illustrate the binding of DHHC3 target with the drug PCC16. The corrected Fig. 4A is provided below. This unintentional mistake does not affect the conclusions of the study. The authors apologize for any inconvenience this may have caused.
Amended Fig. 4
The original article has also been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41419-024-07073-y.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shi, YY., Fan, G., Tan, R. et al. Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates. Cell Death Dis 15, 839 (2024). https://doi.org/10.1038/s41419-024-07182-8
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-024-07182-8
